Charlie Birts

Dr Charlie Birts is a Lecturer in Antibody Therapeutics at the University of Southampton School of Biological Sciences, focusing on breast cancer research. He integrates metabolic and immunological approaches to develop novel antibody-based therapies for secondary breast cancers.

• Education: First-Class Honours in Biochemistry and Pharmacology (2003), PhD in Phospholipase Role in Inflammation
• Affiliation: University of Southampton (2007-present), Faculty of Medicine (2007-2018), School of Biological Sciences (2018-present)

His research examines the tumor microenvironment, metabolic regulation, and antibody-glycan interactions in metastatic breast cancer. Recent work explores obesity-cancer links, metabolic interventions, and glycan biomarkers.

Key article trends include 3D in vitro models, immune cell infiltration, crown-like structures, and metabolic regulation of tumor progression. His work spans basic science, translational research, and clinical analysis.

• Scientific Awards: Faculty of Medicine Postdoctoral Career Track Award (2014), ESPEN Research Fellowship (2016)
• Teaching: Module Coordinator for Biomedical Technology, Lecturer in Biochemistry, Cell Biology, Immunology, and Pharmacology